Dementia with Lewy bodies (DLB), the second most common type of dementia, requires a multifactorial approach to reduce symptoms.

Tongue coating analysis reveals potential biomarkers for early Parkinson's disease detection, offering a non-invasive and ...

A mutant DJ-1 gene causes recessive Parkinson's disease, but the molecular mechanism of this process has not been well ...

To understand how DJ-1 hydrolyzes cyclic 3-phosphoglyceric anhydride—a highly reactive, toxic cellular metabolite—researchers ...

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...

In a field where treatment options are limited and rapid disease progression remains difficult to manage, Alterity ...

Acquires a highly selective and brain penetrant NLRP3 inhibitor from Mwyngil Therapeutics Company's lead candidate BT-267, a ...

Parkinson’s disease is the second most prevalent neurodegenerative disease and presents a global health challenge. About 90,000 people are diagnosed in the U ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are caused by genetics, the cause is unknown in most.

Groundbreaking new research released from Northwestern Medicine discovered that a usually harmless virus in the blood, may be triggering Parkinson's disease.

A team of Chicago area scientists discovered that the human pegivirus, a blood-borne virus otherwise not known to cause any specific disease, may be associated with Parkinson’s disease and ma… ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy of Neurology Conference to present findings from his patient survey ...